An Exploratory Clinical Study of GC012F Injection for Refractory gMG

Summary

This study is a single-arm, open-label early exploratory clinical trial designed to evaluate the safety, tolerability, and preliminary efficacy of GC012F injection in subjects with refractory GMG. Additionally, the study aims to assess the pharmacokinetic (PK), pharmacodynamic (PD) characteristics, and immunogenicity of GC012F injection in subjects.

Timeline

Start

2024-12-01

Primary completion

2027-06-01

Completion

2027-10-01

Drugs

Indications